Floatz logo

Zelenectide Pevedotin

Advanced Solid Tumor

BicycleTx LimitedPhase 1/2Active
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
59/ 100

Competitive context

1411 Active assets in the Advanced Solid Tumor cohort.

View all 50

Same molecule, other indications

Zelenectide Pevedotin is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
Hormone Receptor Positive, HER2-negative NeoplasmsDormant
CCC
Indicative ·
48 / 100
View asset →
urinary bladder neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →